InMed Pharmaceuticals Plunges 10.41% Amid Volatile Trading

InMed's stock price experienced a significant drop of 10.41% during the pre-market session on July 15, 2025, marking a notable decline for the company.

InMed Pharmaceuticals Inc. has seen a volatile trading period, with its stock price fluctuating between $2.77 and $3.28 on July 14, 2025. The stock gained 15.27% on the last trading day, rising from $2.75 to $3.17. However, the stock has fallen in 7 of the last 10 days, indicating a downward trend. The volume of shares traded has increased, which is typically seen as a positive technical sign.

The stock is currently in a weak rising trend in the short term, with a further rise within the trend expected. The stock holds buy signals from both short and long-term moving averages, but there is a general sell signal due to the long-term average being above the short-term average. Support levels are at $2.86 and $2.89, and a breakdown below these levels could issue sell signals. The stock is considered to be "very high risk" due to its volatility, with daily movements of up to 18.41%.

For the upcoming trading day on July 15, 2025, the stock is expected to open at $3.07 and move between $2.98 and $3.36, giving a possible trading interval of +/-$0.379 (+/-12.71%) up or down from the last closing price. The stock is closer to the support level at $3.16 than the resistance at $3.36, making the trading risk/reward intra-day attractive. Several short-term signals, along with a general good trend, suggest that the current level may hold a buying opportunity for InMed Pharmaceuticals Inc. stock to perform well in the short term.